Nos tutelles

CNRS INSA de Lyon Université Lyon1

Nos partenaires

Bayer CropScience

Rechercher




Accueil > Actualités

vendredi 21 octobre - 11h00

Journal club animé par Yvan Rahbé. Discussion autour de l’article suivant :

Nat Microbiol. 2016 Sep 12 ;1:16162. doi : 10.1038/nmicrobiol.2016.162.
Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.

Salle de réunion bat. Lwoff, sous-sol.

Abstract
With the recent emergence of reports on resistant Gram-negative ’superbugs’, infections caused by multidrug-resistant (MDR) Gram-negative bacteria have been named as one of the most urgent global health threats due to the lack of effective and biocompatible drugs. Here, we show that a class of antimicrobial agents, termed ’structurally nanoengineered antimicrobial peptide polymers’ (SNAPPs) exhibit sub-μM activity against all Gram-negative bacteria tested, including ESKAPE and colistin-resistant and MDR (CMDR) pathogens, while demonstrating low toxicity. SNAPPs are highly effective in combating CMDR Acinetobacter baumannii infections in vivo, the first example of a synthetic antimicrobial polymer with CMDR Gram-negative pathogen efficacy. Furthermore, we did not observe any resistance acquisition by A. baumannii (including the CMDR strain) to SNAPPs. Comprehensive analyses using a range of microscopy and (bio)assay techniques revealed that the antimicrobial activity of SNAPPs proceeds via a multimodal mechanism of bacterial cell death by outer membrane destabilization, unregulated ion movement across the cytoplasmic membrane and induction of the apoptotic-like death pathway, possibly accounting for why we did not observe resistance to SNAPPs in CMDR bacteria. Overall, SNAPPs show great promise as low-cost and effective antimicrobial agents and may represent a weapon in combating the growing threat of MDR Gram-negative bacteria.
PMID : 27617798 DOI : 10.1038/nmicrobiol.2016.162

Voir en ligne : https://www.ncbi.nlm.nih.gov/pubmed...